FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Charles Shapiro

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Living Beings

Survivors

Anatomy

Tumor Cell Line

Co-author Network

Publications

TOP 3
Flavia Pichiorri; Claudia Piovan; Alberto Rocci; Charles L Shapiro; Tiffany Talabere; Stefano Volinia; Jia You; Veronica Balatti; John C Byrd; Luciano Cascione; Jessica Consiglio; Vincenzo Coppola; Luciana De Luca; Michael A Freitas; Pierluigi Gasparini; Jingwen Guan; Craig C Hofmeister; Alessandro Lagana; Guido Marcucci; Gerard Nuovo; Dario Palmieri; Carlo M Croce
In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation.
Rachel M Layman; Maryam B Lustberg; Melinda Lynn; Ewa Mrozek; Susan Ottman; Bhuvaneswari Ramaswamy; Raquel Reinbolt; Amy S Ruppert; Anissa Bingman; Sarah Carothers; Eric H Kraut; Robert Wesolowski; Charles L Shapiro
Severe and prolonged lymphopenia observed in patients treated with bendamustine and erlotinib for metastatic triple negative breast cancer.
Maryam B Lustberg; Ewa Mrozek; Shubham Pant; Bhuvaneswari Ramaswamy; Amy S Ruppert; Jessie L Au; Michael Berger; Lisa Brenner; Ling Chen; Michael Grever; Rhonda R Jensen; Tong Shen; Donna Shiels; Yong Wei; M Guillaume Wientjes; Charles L Shapiro
Phase I/II trial of non-cytotoxic suramin in combination with weekly paclitaxel in metastatic breast cancer treated with prior taxanes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Charles Shapiro (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Flavia Pichiorri; Claudia Piovan; Alberto Rocci; Charles L Shapiro; Tiffany Talabere; Stefano Volinia; Jia You; Veronica Balatti; John C Byrd; Luciano Cascione; Jessica Consiglio; Vincenzo Coppola; Luciana De Luca; Michael A Freitas; Pierluigi Gasparini; Jingwen Guan; Craig C Hofmeister; Alessandro Lagana; Guido Marcucci; Gerard Nuovo; Dario Palmieri; Carlo M Croce
In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation.
The Journal of experimental medicine 2013;210(5):951-68.
2013: Rachel M Layman; Maryam B Lustberg; Melinda Lynn; Ewa Mrozek; Susan Ottman; Bhuvaneswari Ramaswamy; Raquel Reinbolt; Amy S Ruppert; Anissa Bingman; Sarah Carothers; Eric H Kraut; Robert Wesolowski; Charles L Shapiro
Severe and prolonged lymphopenia observed in patients treated with bendamustine and erlotinib for metastatic triple negative breast cancer.
Cancer chemotherapy and pharmacology 2013;71(5):1183-90.
2012: Maryam B Lustberg; Ewa Mrozek; Shubham Pant; Bhuvaneswari Ramaswamy; Amy S Ruppert; Jessie L Au; Michael Berger; Lisa Brenner; Ling Chen; Michael Grever; Rhonda R Jensen; Tong Shen; Donna Shiels; Yong Wei; M Guillaume Wientjes; Charles L Shapiro
Phase I/II trial of non-cytotoxic suramin in combination with weekly paclitaxel in metastatic breast cancer treated with prior taxanes.
Cancer chemotherapy and pharmacology 2012;70(1):49-56.
2012: Ewa Mrózek; Susan Ottman; Bhuvaneswari Ramaswamy; Larry Schaaf; Rachel Layman; Xiaobai Li; Charles L Shapiro
Phase II trial of exemestane in combination with fulvestrant in postmenopausal women with advanced, hormone-responsive breast cancer.
Clinical breast cancer 2012;12(2):151-6.
2012: Bhuvaneswari Ramaswamy; Charles L Shapiro; G Somlo; Vered Stearns; R Swaby; K Bhalla; P Christos; E Chuang; B Cohen; Igor Espinoza-Delgado; Warren C Fiskus; M Goetz; D L Hershman; Thehang Luu; C Pellegrino; Joseph A Sparano
Phase I-II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo.
Breast cancer research and treatment 2012;132(3):1063-72.
2012: Christopher P Fagundes; Monica E Lindgren; Charles L Shapiro; Janice K Kiecolt-Glaser
Child maltreatment and breast cancer survivors: social support makes a difference for quality of life, fatigue and cancer stress.
European journal of cancer (Oxford, England : 1990) 2012;48(5):728-36.
2012: Zhengang Peng; Charles L Shapiro; Rulong Shen; Kun-Yu Teng; Ying-Wei Li; Huey-Jen L Lin
Epigenetic repression of RARRES1 is mediated by methylation of a proximal promoter and a loss of CTCF binding.
PloS one 2012;7(5):e36891.
2011: Angela M Gordon; Shelley Hurwitz; Charles L Shapiro; Meryl Leboff
Premature ovarian failure and body composition changes with adjuvant chemotherapy for breast cancer.
Menopause (New York, N.Y.) 2011;18(11):1244-8.
2011: Christopher P Fagundes; Jean-Philippe Gouin; Beom Seuk Hwang; William B Malarkey; David M Murray; Charles L Shapiro; John J Sollers; Julian F Thayer; Janice K Kiecolt-Glaser
Sympathetic and parasympathetic activity in cancer-related fatigue: more evidence for a physiological substrate in cancer survivors.
Psychoneuroendocrinology 2011;36(8):1137-47.
2011: Maryam B Lustberg; Ewa Mrozek; Stephen P Povoski; Bhuvaneswari Ramaswamy; Amy S Ruppert; Donna R Shiels; Sugimoto Yasuro; Weiqiang Zhao; Rebecca M Ziegler; Robert W Brueggemeier; Rachel M Layman; Amy M Lehman; Charles L Shapiro
Phase II trial of neoadjuvant exemestane in combination with celecoxib in postmenopausal women who have breast cancer.
Clinical breast cancer 2011;11(4):221-7.
2011: Tao Zuo; Ta-Ming Liu; Xun Lan; Yu-I Weng; Rulong Shen; Fei Gu; Yi-Wen Huang; Sandya Liyanarachchi; Daniel E Deatherage; Pei-Yin Hsu; Cenny Taslim; Bhuvaneswari Ramaswamy; Charles L Shapiro; Huey-Jen L Lin; Alfred S L Cheng; Victor X Jin; Hui-Ming (Tim) Huang
Epigenetic silencing mediated through activated PI3K/AKT signaling in breast cancer.
Cancer research 2011;71(5):1752-62.
2010: Therese B Bevers; Deborah K Armstrong; Banu Arun; Robert W Carlson; Kenneth H Cowan; Mary B Daly; Irvin Fleming; Judy E Garber; Mary L Gemignani; William J Gradishar; Helen Krontiras; Swati Kulkarni; Christine Laronga; Loretta Loftus; Deborah MacDonald; Martin Mahoney; Sofia D Merajver; Ingrid Meszoely; Lisa A Newman; Elizabeth Pritchard; Victoria Seewaldt; Rena V Sellin; Charles L Shapiro; John H Ward
Breast cancer risk reduction.
Journal of the National Comprehensive Cancer Network : JNCCN 2010;8(10):1112-46.
2010: Judy E Garber; Susan Halabi; Sara M Tolaney; Ellen Kaplan; Laura Archer; James N Atkins; Stephen Edge; Charles L Shapiro; Lynn Dressler; Electra D Paskett; Electra M Paskett; Gretchen Kimmick; James Orcutt; Anthony Scalzo; Eric P Winer; Ellis Levine; Nasir Shahab; Nancy Berliner
Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer.
Journal of the National Cancer Institute 2010;102(13):942-9.
2010: Barbara L Andersen; Lisa M Thornton; Charles L Shapiro; William B Farrar; Bethany L Mundy; Hae-Chung Yang; William E Carson
Biobehavioral, immune, and health benefits following recurrence for psychological intervention participants.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(12):3270-8.
2010: Mira L Katz; Paul L Reiter; Sandy Corbin; Janet S de Moor; Electra D Paskett; Charles L Shapiro
Are rural Ohio Appalachia cancer survivors needs different than urban cancer survivors?
Journal of cancer survivorship : research and practice 2010;4(2):140-8.
2010: Bhuvaneswari Ramaswamy; Tanios Bekaii-Saab; Larry J Schaaf; Gregory B Lesinski; David M Lucas; Donn C Young; Amy S Ruppert; John C Byrd; Kristy Culler; Diedre Wilkins; John J Wright; Michael R Grever; Charles L Shapiro
A dose-finding and pharmacodynamic study of bortezomib in combination with weekly paclitaxel in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2010;66(1):151-8.
2010: Yin Ye; De-Tao Yin; Li Chen; Quansheng Zhou; Rulong Shen; Gang He; Qingtao Yan; Zhenyu Tong; Andrew C Issekutz; Charles L Shapiro; Sanford H Barsky; Haifan Lin; Jian-Jian Li; Jian-Xin Gao
Identification of Piwil2-like (PL2L) proteins that promote tumorigenesis.
PloS one 2010;5(10):e13406.
2009: Tanios S Bekaii-Saab; Julie M Roda; Kristan D Guenterberg; Bhuvanaswari Ramaswamy; Donn C Young; Amy K Ferketich; Tammy A Lamb; Michael R Grever; Charles L Shapiro; William E Carson
A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies.
Molecular cancer therapeutics 2009;8(11):2983-91.
2009: Aruna Mani; Julie Roda; Donn Young; Michael A Caligiuri; Gini F Fleming; Peter Kaufman; Adam Brufsky; Susan Ottman; William E Carson; Charles L Shapiro
A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer (MBC) who have previously failed trastuzumab.
Breast cancer research and treatment 2009;117(1):83-9.
2009: Lawrence N Shulman; Karen Syrjala; Marci Campbell; Lisa Diller; Sheldon Greenfield; Linda A Jacobs; Barbara Jones; Marjorie Kagawa-Singer; Alfred C Marcus; Mary S McCabe; Sheila Santacroce; Charles L Shapiro; Patricia A Ganz
Cancer care and cancer survivorship care in the United States: will we be able to care for these patients in the future?
Journal of oncology practice / American Society of Clinical Oncology 2009;5(3):119-23.
2009: S J Beyer; R E Jimenez; Charles L Shapiro; Je-Yoel Cho; Sissy M Jhiang
Do cell surface trafficking impairments account for variable cell surface sodium iodide symporter levels in breast cancer?
Breast cancer research and treatment 2009;115(1):205-12.
2009: Bhuvaneswari Ramaswamy; Sarmila Majumder; Satavisha Roy; Kalpana Ghoshal; Huban Kutay; Jharna Datta; Mamoun Younes; Charles L Shapiro; Tasneem Motiwala; Samson T Jacob
Estrogen-mediated suppression of the gene encoding protein tyrosine phosphatase PTPRO in human breast cancer: mechanism and role in tamoxifen sensitivity.
Molecular endocrinology (Baltimore, Md.) 2009;23(2):176-87.
2008: Electra D Paskett; James E Herndon; Jeannette M Day; Nancy N Stark; Eric P Winer; Stephen S Grubbs; Michael D Pavy; Charles L Shapiro; Marcy A List; Martee Hensley; Michelle A Naughton; Alice B Kornblith; Karleen R Habin; Gini F Fleming; Marisa A Bittoni
Applying a conceptual model for examining health-related quality of life in long-term breast cancer survivors: CALGB study 79804.
Psycho-oncology 2008;17(11):1108-20.
2008: Lisa M Thornton; William E Carson; Charles L Shapiro; William B Farrar; Barbara L Andersen
Delayed emotional recovery after taxane-based chemotherapy.
Cancer 2008;113(3):638-47.
2008: E Mrozek; J Kolesar; D Young; Joan Allen; M Villalona-Calero; Charles L Shapiro
Phase II study of sequentially administered low-dose mitomycin-C (MMC) and irinotecan (CPT-11) in women with metastatic breast cancer (MBC).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(8):1417-22.
2008: Shu-Chuan Weng; Yoko Kashida; Samuel K Kulp; Dasheng Wang; Robert W Brueggemeier; Charles L Shapiro; Ching-Shih Chen
Sensitizing estrogen receptor-negative breast cancer cells to tamoxifen with OSU-03012, a novel celecoxib-derived phosphoinositide-dependent protein kinase-1/Akt signaling inhibitor.
Molecular cancer therapeutics 2008;7(4):800-8.
2008: Andrew D Seidman; Donald Berry; Constance Cirrincione; Lyndsay Harris; Hyman Muss; Paul Kelly Marcom; Grandella Gipson; Harold J Burstein; Diana E Lake; Charles L Shapiro; Peter Ungaro; Larry Norton; Eric Winer; Clifford Hudis
Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B protocol 9840.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(10):1642-9.
2008: Hae-Chung Yang; Lisa M Thornton; Charles L Shapiro; Barbara L Andersen
Surviving recurrence: psychological and quality-of-life recovery.
Cancer 2008;112(5):1178-87.
2007: Therese B Bevers; Deborah K Armstrong; Banu Arun; Robert W Carlson; Kenneth H Cowan; Mary B Daly; Irvin Fleming; Judy E Garber; Mary L Gemignani; William J Gradishar; Helen Krontiras; Swati Kulkarni; Christine Laronga; Tom Lawton; Loretta Loftus; Deborah MacDonald; Martin Mahoney; Sofia D Merajver; Victoria L Seewaldt; Rena V Sellin; Charles L Shapiro; Eva Singletary; John H Ward
Breast cancer risk reduction.
Journal of the National Comprehensive Cancer Network : JNCCN 2007;5(8):676-701.
2007: Joseph R Carver; Charles L Shapiro; Andrea Ng; Linda Jacobs; Cindy Schwartz; Katherine S Virgo; Karen L Hagerty; Mark R Somerfield; David J Vaughn
American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(25):3991-4008.
2007: Barbara L Andersen; Kristen M Carpenter; Hae-Chung Yang; Charles L Shapiro
Sexual well-being among partnered women with breast cancer recurrence.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(21):3151-7.
2007: Hannah M Linden; Charles M Haskell; Stephanie J Green; C Kent Osborne; George W Sledge; Charles L Shapiro; James N Ingle; Danika Lew; Laura F Hutchins; Robert B Livingston; Silvana Martino
Sequenced compared with simultaneous anthracycline and cyclophosphamide in high-risk stage I and II breast cancer: final analysis from INT-0137 (S9313).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(6):656-61.
2006: Peggy L Porter; William E Barlow; I-Tien Yeh; Ming Gang Lin; Xiaopu P Yuan; Elizabeth Donato; George W Sledge; Charles L Shapiro; James N Ingle; Charles M Haskell; Kathy S Albain; James M Roberts; Robert B Livingston; Daniel F Hayes
p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy.
Journal of the National Cancer Institute 2006;98(23):1723-31.
2006: Pearlly S Yan; Chinnambally Venkataramu; Ashraf Ibrahim; Joseph C Liu; Rulong Z Shen; Nils M Diaz; Barbara A Centeno; Frank Weber; Yu-Wei Leu; Charles L Shapiro; Charis Eng; Timothy J Yeatman; Hui-Ming (Tim) Huang
Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(22):6626-36.
2006: Ping-Hui Tseng; Yu-Chieh Wang; Shu-Chuan Weng; Jing-Ru Weng; Chang-Shi Chen; Robert W Brueggemeier; Charles L Shapiro; Ching-Yu Chen; Sandra E Dunn; Michael Pollak; Ching-Shih Chen
Overcoming trastuzumab resistance in HER2-overexpressing breast cancer cells by using a novel celecoxib-derived phosphoinositide-dependent kinase-1 inhibitor.
Molecular pharmacology 2006;70(5):1534-41.
2006: Ewa Mrozek; Bhuvaneswari Ramaswamy; Donn Young; Chris A Rhoades; Kari Kendra; Joan Allen; Tim Moore; Marsha Hauger; Holly Watson; Nancy Merriman; Padma Nadella; Miguel A Villalona-Calero; Charles L Shapiro
Phase II study of weekly docetaxel and capecitabine in patients with metastatic breast cancer.
Clinical breast cancer 2006;7(2):141-5.
2006: Hollie A Breedlove; Anne M Smith; Raymond F Burk; Kristina E Hill; Charles L Shapiro
Serum selenium measurements in women with early-stage breast cancer with and without chemotherapy-induced ovarian failure.
Breast cancer research and treatment 2006;97(3):225-30.
2006: Bhuvaneswari Ramaswamy; Anthony D Elias; Nicole Kelbick; Angela Dodley; Mark Morrow; Marsha Hauger; Joan Allen; Chris A Rhoades; Kari Kendra; Helen X Chen; S Gail Eckhardt; Charles L Shapiro
Phase II trial of bevacizumab in combination with weekly docetaxel in metastatic breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(10):3124-9.
2006: Richard L Theriault; J Sybil Biermann; Elizabeth Brown; Adam Brufsky; Laurence Demers; Ravinder K Grewal; Theresa Guise; Rebecca D Jackson; Kevin McEnery; Donald A Podoloff; Peter M Ravdin; Charles L Shapiro; Matthew Smith; Catherine Van Poznak
NCCN Task Force Report: Bone Health and Cancer Care.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4 Suppl 2():S1-20; quiz S21-2.
2005: Charles L Shapiro
Is pamidronate effective in preventing chemotherapy-induced bone loss?
Nature clinical practice. Endocrinology & metabolism 2005;1(2):78-9.
2005: Barbara L Andersen; Charles L Shapiro; William B Farrar; Timothy R Crespin; Sharla M. Wells
Psychological responses to cancer recurrence.
Cancer 2005;104(7):1540-7.
2005: Bhuvaneswari Ramaswamy; Stephen P Povoski; Chris A Rhoades; Joan Allen; Marsha Hauger; Donn Young; William E Burak; William B Farrar; Lisa Yee; Kari Kendra; Sivagurunathan Somasundaram; Robert Z Orlowski; Charles L Shapiro
Phase II trial of neoadjuvant chemotherapy with docetaxel followed by epirubicin in stage II/III breast cancer.
Breast cancer research and treatment 2005;93(1):67-74.
2005: Charles L Shapiro
Aromatase inhibitors and bone loss: risks in perspective.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(22):4847-9.
2005: E Mrózek; Chris A Rhoades; Joan Allen; Erinn M Hade; Charles L Shapiro
Phase I trial of liposomal encapsulated doxorubicin (Myocet; D-99) and weekly docetaxel in advanced breast cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(7):1087-93.
2005: Robert W Brueggemeier; Edgar S Díaz-Cruz; Pui-Kai Li; Sugimoto Yasuro; Young C Lin; Charles L Shapiro
Translational studies on aromatase, cyclooxygenases, and enzyme inhibitors in breast cancer.
The Journal of steroid biochemistry and molecular biology 2005;95(1-5):129-36.
2005: Edgar S Díaz-Cruz; Charles L Shapiro; Robert W Brueggemeier
Cyclooxygenase inhibitors suppress aromatase expression and activity in breast cancer cells.
The Journal of clinical endocrinology and metabolism 2005;90(5):2563-70.
2005: Jui-Wen Huang; Chung-Wai Shiau; Ya-Ting Yang; Samuel K Kulp; Kuen-Feng Chen; Robert W Brueggemeier; Charles L Shapiro; Ching-Shih Chen
Peroxisome proliferator-activated receptor gamma-independent ablation of cyclin D1 by thiazolidinediones and their derivatives in breast cancer cells.
Molecular pharmacology 2005;67(4):1342-8.
2005: Ewa Mrozek; Charles L Shapiro
Survivorship and complications of treatment in breast cancer.
Clinical advances in hematology & oncology : H&O 2005;3(3):211-22, 238.
2005: Charles L Shapiro; Gary Phillips; Catherine Van Poznak; Rebecca D Jackson; Meryl Leboff; Stacy Woodard; Stan Lemeshow
Baseline bone mineral density of the total lumbar spine may predict for chemotherapy-induced ovarian failure.
Breast cancer research and treatment 2005;90(1):41-6.
2004: Michael S Ewer; Francis J Martin; Craig Henderson; Charles L Shapiro; Robert S Benjamin; Alberto Gabizon
Cardiac safety of liposomal anthracyclines.
Seminars in oncology 2004;31(6 Suppl 13):161-81.
2004: Nicholas J Robert; Charles L Vogel; I Craig Henderson; Joseph A Sparano; Melvin R Moore; Paula Silverman; Beth Overmoyer; Charles L Shapiro; John W Park; Gail T Colbern; Eric P Winer; Alberto Gabizon
The role of the liposomal anthracyclines and other systemic therapies in the management of advanced breast cancer.
Seminars in oncology 2004;31(6 Suppl 13):106-46.
2004: Doreen M Agnese; Fouza Yusuf; John L Wilson; Charles L Shapiro; Amy Lehman; William E Burak
Trends in breast cancer presentation and care according to age in a single institution.
American journal of surgery 2004;188(4):437-9.
2004: Barbara L Andersen; William B Farrar; Deanna M Golden-Kreutz; Ronald Glaser; Charles F Emery; Timothy R Crespin; Charles L Shapiro; William E Carson
Psychological, behavioral, and immune changes after a psychological intervention: a clinical trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(17):3570-80.
2004: Robin Parihar; Padma Nadella; Adrian Lewis; Rhonda Jensen; Carrie De Hoff; Julie Dierksheide; Anne M VanBuskirk; Cynthia M Magro; Donn C Young; Charles L Shapiro; William E Carson
A phase I study of interleukin 12 with trastuzumab in patients with human epidermal growth factor receptor-2-overexpressing malignancies: analysis of sustained interferon gamma production in a subset of patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(15):5027-37.
2004: William E Carson; Charles L Shapiro; Timothy R Crespin; Lisa M Thornton; Barbara L Andersen
Cellular immunity in breast cancer patients completing taxane treatment.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(10):3401-9.
2003: Bhuvaneswari Ramaswamy; Charles L Shapiro
Osteopenia and osteoporosis in women with breast cancer.
Seminars in oncology 2003;30(6):763-75.
2003: Sister Mary Andrew Matesich; Charles L Shapiro
Second cancers after breast cancer treatment.
Seminars in oncology 2003;30(6):740-8.
2003: Bhuvaneswari Ramaswamy; Charles L Shapiro
Phase II trial of bevacizumab in combination with docetaxel in women with advanced breast cancer.
Clinical breast cancer 2003;4(4):292-4.
2003: Stacy Woodard; Padma Nadella; Linda Kotur; John Wilson; William E Burak; Charles L Shapiro
Older women with breast carcinoma are less likely to receive adjuvant chemotherapy: evidence of possible age bias?
Cancer 2003;98(6):1141-9.
2003: Bhuvaneswari Ramaswamy; Charles L Shapiro
Bisphosphonates in the prevention and treatment of bone metastases.
Oncology (Williston Park, N.Y.) 2003;17(9):1261-70; discussion 1270-2, 1277-8, 1280.
2003: Yiqing Xu; Charles L Shapiro
Rationale for mitomycin and irinotecan use in advanced breast cancer.
Oncology (Williston Park, N.Y.) 2003;17(5 Suppl 5):25-8.
2002: Chau Dang; Charles L Shapiro; Clifford Hudis
Potential role of selective COX-2 inhibitors in cancer management.
Oncology (Williston Park, N.Y.) 2002;16(5 Suppl 4):30-6.
2002: William K Oh; Judith Manola; Daniel J George; Abby Fierman; Pamela Fontaine-Rothe; Stephanie Morrissey; Judith Prisby; Donald S Kaufman; Charles L Shapiro; Philip W Kantoff; Matthew R Smith
A phase II trial of interferon-alpha and toremifene in advanced renal cell cancer patients.
Cancer investigation 2002;20(2):186-91.
2001: Charles L Shapiro; J Manola; Meryl Leboff
Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(14):3306-11.
2001: Charles L Shapiro; A Recht
Side effects of adjuvant treatment of breast cancer.
The New England journal of medicine 2001;344(26):1997-2008.
2001: A J Janov; M Tulecke; A O'Neill; S Lester; Peter M Mauch; J Harris; S J Schnitt; Charles L Shapiro
Clinical and pathologic features of breast cancers in women treated for Hodgkin's disease: a case-control study.
The breast journal 2001;7(1):46-52.
2001: Arnold F Jacobson; Charles L Shapiro; Annick D Van den Abbeele; W D Kaplan
Prognostic significance of the number of bone scan abnormalities at the time of initial bone metastatic recurrence in breast carcinoma.
Cancer 2001;91(1):17-24.
2000: William K Oh; Judith Manola; A A Renshaw; D Brodkin; K R Loughlin; Jerome P Richie; Charles L Shapiro; Philip W Kantoff
Smoking and alcohol use may be risk factors for poorer outcome in patients with clear cell renal carcinoma.
Urology 2000;55(1):31-5.
1999: Charles L Shapiro; T Ervin; Lauri Welles; Nozar Azarnia; J Keating; Daniel F Hayes
Phase II trial of high-dose liposome-encapsulated doxorubicin with granulocyte colony-stimulating factor in metastatic breast cancer. TLC D-99 Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(5):1435-41.
1999: Charles L Shapiro; J Keating; JE Angell; M Janicek; Rebecca Gelman; Daniel F Hayes; Meryl Leboff
Monitoring therapeutic response in skeletal metastases using dual-energy x-ray absorptiometry: a prospective feasibility study in breast cancer patients.
Cancer investigation 1999;17(8):566-74.
1998: Charles L Shapiro; PH Hardenbergh; Rebecca Gelman; D Blanks; P Hauptman; Abram Recht; Daniel F Hayes; Jay R Harris; I Craig Henderson
Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(11):3493-501.
1997: B L Samuels; D R Hollis; Gary Rosner; D L Trump; Charles L Shapiro; N J Vogelzang; R L Schilsky
Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B study.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(11):1977-84.
1997: Charles L Shapiro; Lois Jeanne Ayash; Iain Webb; Rebecca Gelman; J Keating; L Williams; George D Demetri; P Clark; A Elias; David B Duggan; Daniel F Hayes; David D Hurd; I Craig Henderson
Repetitive cycles of cyclophosphamide, thiotepa, and carboplatin intensification with peripheral-blood progenitor cells and filgrastim in advanced breast cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):674-83.
1995: Charles L Shapiro; Bruce J Dezube; O Tretyakov; J Wright; B Cap; I Craig Henderson; Daniel F Hayes
Dose escalation of N,N',N"-triethylenethiophosphoramide combined with pentoxifylline for advanced breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(8):791-6.
1995: Charles L Shapiro
Central venous access catheters.
Surgical oncology clinics of North America 1995;4(3):443-51.
1995: Daniel F Hayes; I Craig Henderson; Charles L Shapiro
Treatment of metastatic breast cancer: present and future prospects.
Seminars in oncology 1995;22(2 Suppl 5):5-19; discussion 19-21.
1994: Charles L Shapiro; I C Henderson
Late cardiac effects of adjuvant therapy: too soon to tell?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(3):196-8.
1994: Charles L Shapiro; I Craig Henderson
Adjuvant therapy of breast cancer.
Hematology/oncology clinics of North America 1994;8(1):213-31.
1994: Charles L Shapiro
Bisphosphonates in breast cancer patients with skeletal metastases.
Hematology/oncology clinics of North America 1994;8(1):153-63.
1994: Charles L Shapiro; Abram Recht
Late effects of adjuvant therapy for breast cancer.
Journal of the National Cancer Institute. Monographs 1994;(16):101-12.
1993: Charles L Shapiro; Daniel F Hayes
Current recommendations on breast cancer treatment.
Contemporary internal medicine 1993;5(8):35-40, 44-5.
1993: Charles L Shapiro; Daniel F Hayes
Breast cancer screening and prevention.
Contemporary internal medicine 1993;5(7):60-9.
1993: Charles L Shapiro; Rebecca Gelman; Daniel F Hayes; R Osteen; A Obando; George P Canellos; Emil Frei; I Craig Henderson
Comparison of adjuvant chemotherapy with methotrexate and fluorouracil with and without cyclophosphamide in breast cancer patients with one to three positive axillary lymph nodes.
Journal of the National Cancer Institute 1993;85(10):812-7.
1993: Charles L Shapiro
Relevance of quality of life assessment to the evaluation of combined-modality therapy.
Seminars in surgical oncology 1993;9(1):65-9.
1992: R F Haft; Charles L Shapiro; N M Gantz; John C Christenson; R J Wallace
Pseudoinfection due to Tsukamurella paurometabolum.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1992;15(5):883.
1992: Charles L Shapiro; Peter M Mauch
Radiation-associated breast cancer after Hodgkin's disease: risks and screening in perspective.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(11):1662-5.
1992: Charles L Shapiro; R F Haft; N M Gantz; G V Doern; John C Christenson; R O'Brien; J C Overall; B A Brown; R J Wallace
Tsukamurella paurometabolum: a novel pathogen causing catheter-related bacteremia in patients with cancer.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1992;14(1):200-3.
1991: Charles L Shapiro; B Y Yeap; J Godleski; Maxine Jochelson; Margaret A Shipp; Arthur T Skarin; George P Canellos
Drug-related pulmonary toxicity in non-Hodgkin's lymphoma. Comparative results with three different treatment regimens.
Cancer 1991;68(4):699-705.
1991: I C Henderson; Charles L Shapiro
Hexamethylmelamine use in the treatment of metastatic breast cancer.
Cancer treatment reviews 1991;18 Suppl A():91-8.
1981: G S Byng; R J Whitaker; Charles L Shapiro; R A Jensen
The aromatic amino acid pathway branches at L-arogenate in Euglena gracilis.
Molecular and cellular biology 1981;1(5):426-38.
1981: Charles L Shapiro; R A Jensen; Karl Wilson; J R Bowen
An assay for activity of arogenate dehydratase base upon the selective oxidation of arogenate.
Analytical biochemistry 1981;110(1):27-30.